title: Differential Effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis.
authors.forename: Ronak
authors.initials: R
authors.lastname: Rajani
authors.forename: John
authors.initials: J
authors.lastname: Smyth
authors.forename: C Geoff
authors.initials: CG
authors.lastname: Koffman
authors.forename: Ian
authors.initials: I
authors.lastname: Abbs
authors.forename: David J A
authors.initials: DJ
authors.lastname: Goldsmith
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000188:drug therapy* / Q000473:pathology*; D011239:Prednisolone / Q000627:therapeutic use*; D012598:Sclerosis; D020123:Sirolimus / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D011239:Prednisolone; D020123:Sirolimus